BCAX
Bicara Therapeutics Inc.
Company Overview
| Mkt Cap | $932.48M | Price | $16.25 |
| Volume | 538.59K | Change | -1.28% |
| P/E Ratio | -13.7 | Open | $16.41 |
| Revenue | -- | Prev Close | $16.46 |
| Net Income | $-68.0M | 52W Range | $7.80 - $28.09 |
| Div Yield | N/A | Target | $32.14 |
| Overall | 53 | Value | 60 |
| Quality | 34 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyBicara Therapeutics Inc. (BCAX) is a leading diversified company in the business industry, currently trading at $16.25 with a market capitalization of $932.48 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows BCAX with a volume of 539K shares. The stock opened down 0.30% from yesterday's close of $16.46. Current analyst estimates project earnings of $-2.32 per share for this year, with next year targeting $-2.71.
BCAX demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for BCAX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 97.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:32 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $16.25 | -1.3% | 538.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW